Shelley J Russek Selected Research

GABA-A Receptors (GABA(A) Receptor)

11/2014	Effect of spontaneous seizures on GABAA receptor α4 subunit expression in an animal model of temporal lobe epilepsy.
7/2013	Polycomblike protein PHF1b: a transcriptional sensor for GABA receptor activity.
12/2012	Molecular pathways controlling inhibitory receptor expression.
11/2012	GABA(A) receptor regulation after experimental traumatic brain injury.
4/2009	Alteration of epileptogenesis genes.
4/2008	Surface expression of GABAA receptors is transcriptionally controlled by the interplay of cAMP-response element-binding protein and its binding partner inducible cAMP early repressor.
11/2006	Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy.
10/2006	Brain-derived neurotrophic factor (BDNF)-induced synthesis of early growth response factor 3 (Egr3) controls the levels of type A GABA receptor alpha 4 subunits in hippocampal neurons.
3/2004	GABAA receptors: building the bridge between subunit mRNAs, their promoters, and cognate transcription factors.
6/2002	Prenatal protein malnutrition reduces beta(2), beta(3) and gamma(2L) GABA(A) receptor subunit mRNAs in the adult septum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shelley J Russek Research Topics

Disease

13	Epilepsy (Aura) 08/2019 - 03/2004
4	Status Epilepticus (Complex Partial Status Epilepticus) 01/2016 - 10/2006
4	Seizures (Absence Seizure) 11/2014 - 08/2006
3	Schizophrenia (Dementia Praecox) 08/2013 - 03/2004
2	Brain Diseases (Brain Disorder) 08/2019 - 07/2013
2	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2019 - 11/2012
2	Temporal Lobe Epilepsy 11/2006 - 10/2006
2	Malnutrition (Nutritional Deficiencies) 09/2003 - 06/2002
1	Epileptic Syndromes 08/2019
1	Stroke (Strokes) 12/2015
1	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 09/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2011
1	Brain Injuries (Brain Injury) 11/2011
1	Alcoholism (Alcohol Abuse) 04/2008
1	Nervous System Diseases (Neurological Disorders) 04/2008
1	Pathologic Processes 04/2008
1	Rett Syndrome (Rett's Disorder) 04/2008
1	Pain (Aches) 08/2006
1	Sleep Initiation and Maintenance Disorders (Insomnia) 08/2006
1	Brain Ischemia (Cerebral Ischemia) 08/2006
1	Neuralgia (Stump Neuralgia) 07/2004
1	Mental Disorders (Mental Disorder) 03/2004
1	Alzheimer Disease (Alzheimer's Disease) 03/2004

Drug/Important Bio-Agent (IBA)

10	GABA-A Receptors (GABA(A) Receptor)IBA 11/2014 - 06/2002
8	gamma-Aminobutyric Acid (GABA)IBA 07/2013 - 06/2002
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2019 - 10/2006
4	Janus KinasesIBA 08/2019 - 10/2008
3	Messenger RNA (mRNA)IBA 11/2014 - 06/2002
3	Aminobutyrates (Aminobutyric Acid)IBA 11/2014 - 12/2012
3	Proteins (Proteins, Gene)FDA Link 11/2014 - 06/2002
2	pregnenolone sulfateIBA 08/2013 - 11/2011
2	NeurosteroidsIBA 08/2013 - 11/2011
2	PregnenoloneIBA 08/2013 - 11/2011
1	Mitogen-Activated Protein KinasesIBA 08/2019
1	Cyclic AMP (AMP, Cyclic)IBA 08/2019
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2015
1	WP1066IBA 09/2015
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2011
1	Protons (Proton)IBA 11/2011
1	Nootropic Agents (Nootropics)IBA 11/2011
1	Protein Isoforms (Isoforms)IBA 11/2011
1	Protein Kinase CIBA 10/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2006
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 10/2006
1	Ligand-Gated Ion ChannelsIBA 08/2006
1	Glutamate Receptors (Glutamate Receptor)IBA 08/2006
1	GABA-B ReceptorsIBA 07/2004
1	Chlordiazepoxide (Elenium)FDA LinkGeneric 06/2002

Therapy/Procedure

2	Therapeutics 08/2019 - 08/2006